✦ LIBER ✦

Monotherapy with docetaxel in the second- or third-line treatment of anthracycline-resistant metastatic breast cancer

✍ Scribed by T. Brodowicz; W.J. Köstler; S. Tomek; I. Vaclavik; V. Herscovici; C. Wiltschke; G.G. Steger; C.C. Zielinski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monotherapy with paclitaxel as third-lin

✍ Jun Kinoshita; Shunsuke Haga; Tadao Shimizu; Hiroshi Imamura; Osamu Watanabe; Hi 📂 Article 📅 2002 🏛 Springer Japan 🌐 English ⚖ 738 KB

Paclitaxel combined with ifosfamide in a

✍ Yong Wha Moon; Joo Hyuk Sohn; Hye Jin Choi; Hyun Chang; Byeong-Woo Park; Seung I 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 175 KB

Weekly topotecan as second- or third-lin

✍ Jaime Coronel; Lucely Cetina; Myrna Candelaria; Aurora González-Fierro; Daimy Ar 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 194 KB

348 A phase II trial of docetaxel in pat

✍ J.P. Guastalla; J. Bonneterre; P. Fumoleau; M. Piccart; M. Tubiana; B. Chevallie 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 269 KB

CE4 COST-EFFECTIVENESS OF CAPECITABINE I

✍ H Lilliu; C Le Pen; G Priol; K Perez-Niddam; R Aultman; L Garrison 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

A phase II trial of docetaxel (Taxotere®

✍ Martina Baur; Allan T. van Oosterom; Véronique Diéras; Michele Tubiana-Hulin; R. 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 385 KB